Genenta Science S p a (GNTA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GNTA Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Genenta Science S p a's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash & cash equivalent6.19
Marketable Securities, Current SH25.34
Cash & Short-term Investments31.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current2.05
Total Current Assets33.58
Equipment/Property/Plant Net0.03
Other Assets, Noncurrent2.11
Total Assets35.72
Liabilities
Accounts Payable, Current AC1.69
Accrued Liabilities, Current AC0.12
Other Liabilities, Current0.56
Total Current Liabilities2.37
Total Long-term Debt0.00
Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent PE0.37
Total Liabilities11.25
Stockholders' Equity
Common Stock Value94.37
Retained Earnings / Accumulated Deficit-70.10
Other Equity0.19
Common Stockholder's Equity24.46
Total Stockholder's Equity24.46
Liabilities & Stockholder's Equity35.72
4 historic quarters locked

Sign in to unlock the full Genenta Science S p a balance sheet history.

About Genenta Science S P A Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: March 31, 2026
  • Source: form20-f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-014387

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.